ALBERT

All Library Books, journals and Electronic Records Telegrafenberg

Your search history is empty.
feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • pharmacokinetics  (686)
  • Spektralphotometrie, Atomabsorption
  • bioavailability
  • Springer  (887)
  • American Meteorological Society
  • American Physical Society (APS)
  • Springer Nature
  • 1990-1994  (572)
  • 1975-1979  (315)
  • 1955-1959
  • 1930-1934
Collection
Keywords
Publisher
  • Springer  (887)
  • American Meteorological Society
  • American Physical Society (APS)
  • Springer Nature
  • Wiley-Blackwell  (19)
Years
Year
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    European journal of nutrition 30 (1991), S. 50-55 
    ISSN: 1436-6215
    Keywords: Maillard-Produkte ; LAL ; Bioverfügbarkeit ; Eisen ; Kupfer ; Zink ; Maillard products ; LAL ; bioavailability ; iron ; copper ; zinc
    Source: Springer Online Journal Archives 1860-2000
    Topics: Agriculture, Forestry, Horticulture, Fishery, Domestic Science, Nutrition , Medicine
    Description / Table of Contents: Summary Bioavailability of iron, copper, and zinc was investigated in suckling rats. The essential trace elements were given once either with several isolated Maillard products and with LAL, respectively, or with differently heat-treated formula diets. The isolated substances revealed effects on bioavailability of all the elements tested, either on the preresorptive or on the postresorptive level. The formula diets affected only the bioavailability of copper — even when fed for several weeks.
    Notes: Zusammenfassung Es wurde die Bioverfügbarkeit von Eisen, Kupfer und Zink untersucht, wenn diese essentiellen Spurenelemente 1. mit einigen isolierten Maillard-Produkten bzw. LAL, oder 2. mit thermisch unterschiedlich belasteten Testnahrungen einmalig an Säuglingsratten verabreicht wurden. Durch die isolierten Testsubstanzen ließen sich bei allen drei Elementen Effekte auf der präresorptiven und/oder postresorptiven Ebene erzielen. Die Testnahrungen beeinflußten — auch wenn sie fünf Wochen lang verfüttert wurden — nur die Bioverfügbarkeit des Kupfers.
    Type of Medium: Electronic Resource
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    European journal of nutrition 29 (1990), S. 219-228 
    ISSN: 1436-6215
    Keywords: Vitamin K ; Menadion ; Menadiol ; Bioverfügbarkeit ; Stabilität ; Geflügel ; vitamin K ; menadione ; menadiol ; bioavailability ; stability ; poultry
    Source: Springer Online Journal Archives 1860-2000
    Topics: Agriculture, Forestry, Horticulture, Fishery, Domestic Science, Nutrition , Medicine
    Description / Table of Contents: Summary A bioassay of vitamin K is described, based on the prothrombin clotting time of 3-week-old, vitamin-K-depleted, and cumatetralyl-sensitized male broiler chicks, using a homologous thrombokinase preparation. With this test it could be shown that the diacetate and dibutyrate esters of menadiol are vitamin-K-active. The bioactivity of menadione from these menadiolesters amounted to about 70 % of the standard menadione from a coated menadione sodium bisulfite (Dohyfral). Menadiol seems to be temperature-resistant under such conditions, whereby two uncoated MSB preparations lost about 60 % of their activity.
    Notes: Zusammenfassung In einem biologischen Testverfahren an Cumatetralyl sensibilisierten Küken konnte in 3 Versuchen anhand des Parameters Thromboplastinzeit mit homologer Thrombokinase gezeigt werden, da\ Menadioldiacetat und Menadioldibutyrat Vitamin-K-wirksam sind. Die biologische Wirksamkeit von Menadion aus diesen Menadiolestern betrug ca. 70 % der Menadionaktivität aus gecoatetem Menadionbisulfit (Dohyfral®). Im Gegensatz zu 2 ungeschützten MSB-Präparationen, welche bei Wärmebelastung ca. 60 % ihrer ursprünglichen Wirkung verloren, waren die Menadiolester temperaturstabil.
    Type of Medium: Electronic Resource
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 3
    ISSN: 1572-8773
    Keywords: taurine ; l-glutamine ; l-histidine ; total parenteral nutrition ; zinc ; bioavailability ; fibroblasts
    Source: Springer Online Journal Archives 1860-2000
    Topics: Biology , Chemistry and Pharmacology
    Notes: Abstract Radioactive zinc was used to study the effect of a binary parenteral nutrient solution, composed of amino acids and glucose, on zinc uptake by fibroblasts. The influence of addition of taurine, l-glutamine and of the increase in l-histidine content of the admixture was assessed. The pure mixture was highly toxic for cells and so it was diluted 1/5 in tyrode buffer with 2% albumin. As compared with cells incubated in the buffer containing albumin, zinc absorption was significantly higher (P 〈 0.05) in the presence of the amino acids of the mixture. Amino acids thus increased bioavailability by displacing zinc bound to albumin. When the histidine concentration in the nutrient medium (4.2 mm) was doubled, inhibition was noted after 30 min of incubation and zinc uptake thereafter remained comparable to that in histidine-free medium. The addition of glutamine (4.2 mm), usually not present in binary mixtures, resulted in significant differences as compared with glutamine-free control medium. Taurine (0.8 mm), led to a constant increase in zinc uptake by fibroblasts as compared with that obtained with taurine-free mixture. However, ultrafiltration showed that taurine was not able to displace zinc from albumin.
    Type of Medium: Electronic Resource
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 4
    Electronic Resource
    Electronic Resource
    Springer
    European journal of nutrition 32 (1993), S. 2-20 
    ISSN: 1436-6215
    Keywords: Aminosäuren ; Proteine ; proteinhaltige Produkte, Bioverfügbarkeit, Biokinetik ; Technologie ; amino acids ; proteins ; protein-containing products ; bioavailability ; biokinetics ; technology
    Source: Springer Online Journal Archives 1860-2000
    Topics: Agriculture, Forestry, Horticulture, Fishery, Domestic Science, Nutrition , Medicine
    Description / Table of Contents: Summary To evaluate the bioavailability of amino acids from proteins and protein-containing products, the area under the postprandial plasma-concentration-time-curve of the amino acids after oral administration needs to be calculated. Therefore, basic values depending on circadian plasma concentration rhythms have to be subtracted from measured values after loading. To determine the relative bioavailability of two tested samples, e.g., a protein-containing product before and after processing or two technologically different preparations of the same protein, it is sufficient to compare their absorption-curves, both corrected by the basic values. For that purpose the mean value-curves corresponding to the group of subjects are used, because the individual courses show considerable differences, in particular due to discontinuous gastric emptying. Enzymatic hydrolysis of a lactalbumin reduces the quantitative bioavailability of the amino acids by 12%. Concerning products used in nutrition of patients and babies, the availability from ready-to-drink liquid products is about 7–10% better than that out of the same dry products in powdered form. Compared with sterilization, ultrahigh heat treatment of milk protein products improves the availability slightly, by about 1%. Processing of dried green peas destined for use in convenience food increases the protein availability by 20%.
    Notes: Zusammenfassung Zur Bestimmung der Bioverfügbarkeit von Aminosäuren aus Proteinen und proteinhaltigen Produkten wird die Fläche unter der postprandialen Plasmakonzentrations-Zeit-Kurve der Aminosäuren nach oraler Zufuhr berechnet. Dies geschieht nach Subtraktion der durch zirkadiane Rhythmen bedingten Leerwerte von den gemessenen Plasmakonzentrationen. Zur Ermittlung der relativen Bioverfügbarkeit von zwei Testpartnern, z.B. einem proteinhaltigen Produkt vor und nach einer bestimmten Behandlung oder zwei technologisch verschiedenen Zubereitungen eines bestimmten Proteins, genügt der Vergleich der beiden bereinigten Resorptionskurven. Hierzu werden die entsprechenden Mittelwertkurven des Probandenkollektivs verwendet, da die individuellen Verlaufskurven insbesondere durch diskontinuierliche Magenentleerung erhebliche Verzerrungen aufweisen. Durch die enzymatische Hydrolyse verschlechtert sich die quantitative Bioverfügbarkeit der Aminosäuren bei einem Lactalbumin um zwölf Prozent. Bei Produkten für die Kranken- bzw. Säuglingsernährung ist die Verfügbarkeit aus fertigen Flüssigprodukten um sieben bis zehn Prozent verbessert gegenüber den gleichartigen Trockenprodukten in Pulverform. Bei ultrahocherhitzten Milcheiweißprodukten wird die Verfügbarkeit gegenüber einfach sterilisierten geringfügig um etwa ein Prozent verbessert. Durch die Präparation getrockneter grüner Erbsen für die Verwendung in Fertiggerichten wird die Verfügbarkeit des Proteins um zwanzig Prozent gesteigert.
    Type of Medium: Electronic Resource
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 5
    ISSN: 1436-5073
    Keywords: Sb(III) ; Sb(V) ; bioavailability ; sediments ; water
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology
    Notes: Abstract A comparative study was made of several methods to speciale Sb(III) and Sb(V) by AAS: 1) Selective extraction of Sb(III) with lactic acid/malachite green graphite furnace-AAS, 2) Sb(III) and total antimony determination by hydride generation-AAS coupled to flow injection, batch, and continuous flow systems. These methods were applied to determine total antimony and Sb(III) in sea and surface water and total antimony in sediments and in soil. For soils different sample pretreatments were used: HNO3-H2SO4-HC1O4, HF-HNO3-H2SO4-HC1O4, cold aqua regia and slurry formation procedures in water and 4M HC1. In each case the recovery of total antimony and the ability to selective determine Sb(III) were studied. The detection limits obtained were 0.01 ng, 0.07 ng, 2.97 ng and 0.21 ppb for GF-AAS, FIA-HG-AAS, HG (Batch)-AAS, and HG (continuous flow)-AAS, respectively.
    Type of Medium: Electronic Resource
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 6
    Electronic Resource
    Electronic Resource
    Springer
    Biodegradation 4 (1993), S. 141-153 
    ISSN: 1572-9729
    Keywords: bioavailability ; biodegradation ; sorption ; oil ; soil
    Source: Springer Online Journal Archives 1860-2000
    Topics: Biology , Energy, Environment Protection, Nuclear Power Engineering , Agriculture, Forestry, Horticulture, Fishery, Domestic Science, Nutrition
    Type of Medium: Electronic Resource
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 7
    Electronic Resource
    Electronic Resource
    Springer
    European journal of clinical pharmacology 42 (1992), S. 101-105 
    ISSN: 1432-1041
    Keywords: Rufloxacin ; pharmacokinetics
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology , Medicine
    Notes: Summary The plasma and urine kinetics of rufloxacin were assessed in healthy volunteers after single (100, 200, 400 and 800 mg) and multiple (300 mg followed by 150 mg daily, Group 1, and 400 mg followed by 200 mg daily, Group 2) oral doses. The kinetics of a single oral dose of 800 mg was assessed in fasting and non-fasting subjects to assess the influence of food intake on drug absorption. The AUCs were 134, 266 and 375 μg · h · ml−1 after 100, 200 and 400 mg, respectively. The AUC after 800 mg p. o. was 715 μg · h · ml −1 in fasting subjects and 614 μg · h · ml−1 in non-fasting subjects. The parameters of the model and the mean renal clearance values indicated some departure from linearity in rufloxacin kinetics. After multiple doses the plasma drug levels during the 6th treatment day were similar to those after the first dose in Group 1 and were about 30–40% higher after the first dose in Group 2. The half-lives after the last dose were much shorter than those estimated in the single dose studies (33–36 h and 50–80 h, respectively).
    Type of Medium: Electronic Resource
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 8
    Electronic Resource
    Electronic Resource
    Springer
    European journal of clinical pharmacology 42 (1992), S. 535-538 
    ISSN: 1432-1041
    Keywords: Meropenem ; Carbapenem ; pharmacokinetics ; uraemia ; haemodialysis
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology , Medicine
    Notes: Summary The pharmacokinetics of IV meropenem (500 mg over 30 min) has been studied in 6 healthy volunteers and 26 patients with various degrees of renal impairment. Blood samples were taken at different times over 24 h in healthy subjects and 36 to 48 h in uraemic patients, and four or five urine samples were collected over 24 or 48 h. Meropenem concentrations in plasma and urine were measured by a microbiological assay. The mean peak plasma concentration of meropenem ranged from 28 to 40 μg·ml−1 and was not affected by the degree of renal impairment. The terminal half-life of meropenem was approximately 1 h in subjects with normal kidney function and it was proportionately increased as renal function decreased. A significant linear relationship between total body clearance and creatinine clearance as well as between renal clearance and creatinine clearance was observed. The mean apparent volume of distribution at steady state was not significantly altered in uraemic patients. The mean cumulative urinary recovery of meropenem in healthy volunteers was 77% of the administered dose and it was significantly decreased in patients with renal impairment. Haemodialysis shortened the elimination half-life, from 9.7 h during the predialysis period to 1.4 h during the dialysis period. The dose of meropenem should be reduced in relation to the decrease in creatinine clearance.
    Type of Medium: Electronic Resource
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 9
    Electronic Resource
    Electronic Resource
    Springer
    European journal of clinical pharmacology 42 (1992), S. 559-560 
    ISSN: 1432-1041
    Keywords: Mefloquine ; Thai subjects ; pharmacokinetics ; Primaquine ; drug interaction ; adverse effects
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology , Medicine
    Type of Medium: Electronic Resource
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
  • 10
    Electronic Resource
    Electronic Resource
    Springer
    European journal of clinical pharmacology 39 (1990), S. 395-397 
    ISSN: 1432-1041
    Keywords: atropine ; exercise ; pharmacokinetics ; healthy volunteers
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology , Medicine
    Notes: Summary Seven healthy males (19–32 y) underwent each of four separate conditions in a repeated measures design. Five of these subjects underwent an additional trial. In four of five trials subjects received 2.0 mg atropine sulfate intramuscularly in the anterolateral portion of the left thigh: at rest (T1); following completion of a single exercise (Ex) bout (T2), (Each bout consisted of 25 min of stationary cycling at 40% VO2 max with 5 min of seated rest), prior to three Ex bouts (T3) and following one and prior to three Ex bouts (T5). Trial 4 (T4) was the same as T3 with the substitution of a saline placebo. Serum samples were collected over a 12 h period and atropine concentration was determined by RIA. Ex trials were compared to T1. Ex prior to atropine (T2) significantly decreased the mean volume of distribution (Vz, 278 vs 2321). Ex in T3 significantly decreased the serum half life (t1/2, 4.2 vs 3.5 h), Vz (278 vs 1981), and clearance (CL, 763 vs 638 ml·min−1) and significantly increased the peak concentration (Cp, 6.7 vs 12.3 ng·ml−1) and area under the curve (AUC, 44.1 vs 53.1 ng·ml−1). In T5, Ex significantly decreased the t1/2 (3.4 h), Vz (182 l) and CL (575 ml·min−1) and significantly increased the absorption rate constant (ka, 0.482 vs 1.1 min−1), elimination rate constant (ke, 0.0012 vs 0.0015 min−1), Cp (14 ng·ml−1) and AUC (53.3 ng·h·ml−1). These results demonstrate that moderate Ex either prior to and/or immediately following drug administration has the capacity to significantly modify atropine pharmacokinetics.
    Type of Medium: Electronic Resource
    Location Call Number Expected Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...